Application of tangerine peel extract in preparation of drugs for curing pulmonary fibrosis

A technology of tangerine peel extract and pulmonary fibrosis, which can be used in drug combinations, pharmaceutical formulations, plant raw materials, etc., and can solve the problems of irritating expectoration and the lack of pulmonary fibroblast effect of tangerine peel.

Inactive Publication Date: 2012-06-20
JIANGSU PROVINCIAL HOSPITAL OF TCM
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the pharmacological research of dried tangerine peel and its active ingredients on the lung, only the volatile oil of tangerine peel has been found to have stimulating and expectorant effects. Research Report on the Function of Lung Fibroblasts

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of tangerine peel extract in preparation of drugs for curing pulmonary fibrosis
  • Application of tangerine peel extract in preparation of drugs for curing pulmonary fibrosis
  • Application of tangerine peel extract in preparation of drugs for curing pulmonary fibrosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Preparation of tangerine peel extract: The specific preparation method is as follows: ① pulverize dried tangerine peel into coarse powder, add appropriate amount of distilled water, soak the surface of the medicinal material for about 1 to 2 cm, heat, reflux for 1 hour, and filter while it is hot. Add appropriate amount of distilled water to the medicine residue and heat to reflux in the same way, filter while hot, and combine the filtrate. ② The filtrate is concentrated under reduced pressure and freeze-dried to obtain dried tangerine peel extract, hereinafter referred to as water extract.

Embodiment 2

[0014] Preparation of tangerine peel extract: The specific preparation method is as follows: ① pulverize dried tangerine peel into coarse powder, add an appropriate amount of 75% ethanol, soak the surface of the medicinal material for about 1 to 2 cm, heat, reflux for 1 hour, and filter while hot. Add appropriate amount of 75% ethanol to the medicine residue to decoct in the same way, and combine the filtrate. ② The filtrate was concentrated under reduced pressure and freeze-dried to obtain dried tangerine peel extract powder, hereinafter referred to as alcohol extract.

Embodiment 3

[0016] Preparation of tangerine peel extract: The specific preparation method is as follows: dry tangerine peel is crushed into coarse powder, and the volatile oil is extracted by steam distillation for many times. The distillates are combined and extracted with ether, and the ether solution is collected and evaporated to dry to obtain tangerine peel extract, hereinafter referred to as volatile oil.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides the application of tangerine peel extract in the preparation of drugs for curing pulmonary fibrosis, which can effectively reduce the collagen deposition and retard the fibrosiscourse. Particularly, the tangerine peel extract is extract obtained by adding tangerine peel to solvent, heating and refluxing, or volatile oil obtained by subjecting tangerine peel to steam distillation. The method for preparing the tangerine peel extract comprises the following steps: (1) pulverizing dry tangerine peel into powder, adding solvent to the powder until the tangerine peel is soaked 1cm to 2cm into the solvent from the surface thereof, heating and refluxing for one hour, and filtering before the tangerine peel is cooled; (2) further adding solvent to the residue by the method in step (1), heating, refluxing and filtering before the residue is cooled; (3) merging the filtrates obtained in steps (1) and (2), vacuum-concentrating and drying the filtrates to obtain the dry tangerine peel extract powder. The invention can reduce the content of hydroxyproline in sera and lungs, which is a biological index closely related to fibrosis, reduce the expression level of transforming growth factors, that is, beta1 protein and messenger ribonucleic acid (mRNA) in lung tissues, effectively inhibit human embryonic lung fibroblasts (HELF) from proliferating and retard the productionof pulmonary alveolitis and the course of pulmonary fibrosis.

Description

Technical field [0001] The invention relates to the application of dried tangerine peel extract in preparing medicines for treating pulmonary fibrosis. Background technique [0002] Idiopathic Pulmonary Fibrosis (IPF) is a special type of chronic interstitial pneumonia confined to the lungs of unknown cause, with progressive dyspnea as the prominent clinical manifestation. Its pathological changes are ordinary Type of interstitial pneumonia is characterized by alveolar epithelial injury, fibroblasts proliferation, and the formation of fibroblast foci. The chest imaging showed diffuse reticulation, nodules shadow or honeycomb-like changes, with the subpleural surrounding the middle and lower lung fields as the most important, while the ground-glass-like changes were less. Pulmonary function presents restrictive ventilatory dysfunction and / or impaired diffusion function, leading to hypoxemia. In recent years, with the gradual deepening of research on pulmonary interstitial diseas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/752A61P11/00A61K131/00
Inventor 周贤梅
Owner JIANGSU PROVINCIAL HOSPITAL OF TCM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap